Companies: 10,795·Total market cap: $144.5T
IDEAYA Biosciences, Inc.

IDEAYA Biosciences, Inc.

IDYANASDAQHealthcare● Active
$29.12
+$0.83(+2.93%)
Market Cap$2.6B
P/E Ratio
52W High$39.28
52W Low$20.455
Overview

IDEAYA Biosciences, Inc.(IDYA)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · IDYA · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.22B$0.01B$0.02B$0.05B$0.03B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.21B$0.00B$0.02B$0.05B$0.03B
Gross Margin %(computed)97.90%45.23%82.86%95.87%93.83%
Operating Expenses
R&D Expenses$0.31B$0.29B$0.13B$0.09B$0.06B
G&A Expenses$0.06B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.37B$0.33B$0.15B$0.11B$0.08B
Operating Income($0.16B)($0.33B)($0.13B)($0.06B)($0.05B)
Operating Margin %(computed)-72.84%-574.85%-122.72%-179.91%
Interest Income$0.05B$0.05B$0.02B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.11B)($0.27B)($0.11B)($0.06B)($0.05B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.11B)($0.27B)($0.11B)($0.06B)($0.05B)
Net Margin %(computed)-51.99%-483.05%-115.17%-178.10%
Per Share & EBITDA
EPS (Basic)$-1.28$-3.36$-1.96$-1.42$-1.41
Wtd Avg Shares0.09B0.08B0.06B0.04B0.04B
EBITDA($0.15B)($0.27B)($0.11B)($0.06B)($0.05B)
EBITDA Margin %(computed)-70.74%-465.91%-111.04%-171.92%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解IDEAYA Biosciences, Inc.

关于IDEAYA Biosciences, Inc.(IDYA)损益表

IDEAYA Biosciences, Inc.(IDYA)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,IDYA实现营收$0.22B,毛利润$0.21B(毛利率97.90%),净利润($0.11B)(净利率-51.99%)。

常见问题

IDYA · 4 问

IDEAYA Biosciences, Inc.(IDYA)2025财年营收为$0.22B,同比up3024.4%。

IDYA revenueIDYA salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08